▶

Vir Biotechnology CEO Sees Progress in the Fight Against Cancer

Founded in 2016, Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Dr. Marianne De Backer, the company's CEO, discusses the strides being made in improving these critical treatments and why she's optimistic about her industry's next big breakthrough. Dr. De Backer speaks with Tim Stenovec and Christina Ruffini on Bloomberg Businessweek Daily. (Source: Bloomberg)